SuperworthSilence Therapeutics market cap SLN
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $929.3M
- Highest close in our data
- $929.3M
- Oct 2026
Silence Therapeutics is worth $929.3M at the close on Oct 23, 2026, at $19.67 a share.
That is up 170% over the last year and up 52% over five years.
Its highest close in our data was $929.3M in Oct 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $929.3M | $210.2M | $929.3M | +217% |
| 2025 | $292.9M | $121.4M | $344.8M | +4% |
| 2024 | $281.3M | $255.5M | $926.4M | −55% |
| 2023 | $624.2M | $191.5M | $624.2M | +37% |
| 2022 | $456.4M | $252.9M | $649.8M | −31% |
| 2021 | $663.4M | $572.3M | $786.2M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Silence Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| SLNSilence Therapeutics | $929.3M |
| ABUSArbutus Biopharma | $831M |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| COLLCollegium Pharmaceutical | $747.5M |
| OMEROmeros | $1.2B |
| CRMDCorMedix | $611.9M |
| PCRXPacira BioSciences | $1.5B |
| ANABAnaptysbio | $1.5B |
| ZVRAZevra Therapeutics | $582.6M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| PBYIPuma Biotechnology | $568.9M |
| Peer median | $789.2M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Silence Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.